Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJames Fisher and Sons Regulatory News (FSJ)

Share Price Information for James Fisher and Sons (FSJ)

Share Price is delayed by 15 minutes
Get Live Data
482.00    -17.00 (-3.41%)
Bid:
481.00
Ask:
490.00
Spread: 9.00 (1.871%)
Market Cap: £243.34m
FSJ Live PriceLast checked at - London Stock Exchange

Intraday James Fisher and Sons Share Chart

AGM trading statement & Covid-19 update

30 Apr 2020 07:00

RNS Number : 3895L
Fisher (James) & Sons plc
30 April 2020
 

 

30 April 2020

 

James Fisher and Sons plc (FSJ.L)

 

AGM trading statement & Covid-19 update

 

Prior to its Annual General Meeting to be held at 11.00 am today, James Fisher & Sons plc ("James Fisher" or "the Group"), the leading marine services provider, delivers a trading statement and updates on its approach to meeting the operational challenges of Covid-19.

 

Our priority throughout the Covid-19 pandemic has been to protect our employees and, within that context, do all we can to continue to provide our services and goods to customers, whilst supporting and maintaining our supply chain. The commitment, support and engagement of our 3,300 employees in stepping up to the challenges we are facing has been remarkable.

 

Trading statement

 

Overall, Group trading in the first quarter was in line with the Board's expectations, which were set at the beginning of the year. However, the effects of Covid-19 were becoming evident towards the end of the quarter and have continued to impact the Group from that point.

 

Travel restrictions are adversely affecting projects in the Asia Pacific region in Specialist Technical and a lack of subsea projects in West Africa is restricting otherwise good progress in Marine Support. Ship-to-Ship services and Tankships have seen little negative impact to date.

 

However, the effects of the Covid-19 lockdown have been exacerbated by a sharp fall in the price of oil and it appears likely that the imbalance between supply of oil and gas and real demand will maintain downward pressure on oil prices for a prolonged period. The Group is well diversified by end market and geography and, whilst in Norway (3% of Group revenue) there has been an immediate drop in demand, other businesses continue to trade in line with our expectations despite logistical challenges. It is evident that the seasonal pick up in the second quarter in Offshore Oil and in Renewables is likely to be delayed.

 

Operational update

 

As stated on 26 March 2020, given the uncertainty of the effects of Covid-19, the Group has taken proactive actions to reduce costs, to optimise cash flow and to protect liquidity. To date, these actions have included the deferral of all discretionary capital expenditure; instituting a hiring freeze; placing approximately 400 employees on temporary furlough and deferring pay for approximately 800 employees of 20%, including the salaries and fees of each Board member.

 

Financial position

 

The Group has a strong balance sheet and good liquidity. This has been supported significantly by the actions we have taken in response to the Covid-19 crisis, including the suspension of the final dividend for the year ended 31 December 2019, as reported on 26 March 2020.

 

On an IAS 17 basis, net debt at 31 December 2019 was £203m, with c.£42m of headroom. Committed facilities were increased by £30m in March 2020 to £280m and headroom at 31 March 2020 was £64m, with a further £13m of headroom on uncommitted overdraft facilities.

 

Financial guidance withdrawn

 

It is impossible to forecast with any reliability what overall impact Covid-19 will have on the Group; this will depend on how long the crisis lasts and on how quickly our businesses recover. Similarly, the effects of the oversupply of oil and gas remain difficult to predict. Mindful that the landscape can change rapidly, therefore, we have withdrawn financial guidance for FY2020 and will update investors when we have a clearer view of the likely outcome.

 

Conclusion

 

James Fisher is well diversified by geographical sector and by end market; this provides resilience to profitability and cash flow, notably in the current challenging environment. We continue to closely monitor our business and will not hesitate to take swift and decisive action where necessary to ensure the Group is well placed to provide long term value to our shareholders.

 

 

 

For further information:

James Fisher and Sons plc

Eoghan O'Lionaird

Stuart Kilpatrick

Chief Executive Officer

Group Finance Director

020 7614 9508

FTI Consulting

Richard Mountain

Susanne Yule

 

0203 727 1340

 

 

 

 

Forward-looking statements

This announcement contains statements which are, or may be deemed to be, "forward-looking statements" which are prospective in nature. All statements other than statements of historical fact are forward-looking statements. By their nature, forward-looking statements are subject to a number of known and unknown risks, uncertainties and contingencies, and actual results and events could differ materially from those currently being anticipated as reflected in such statements. Factors may cause future outcomes to differ from those foreseen or implied, many of which are beyond James Fisher's control or influence. Any forward-looking statements speak only as of the date of this announcement and have not been audited or otherwise independently verified. Past performance should not be taken as an indication or guarantee of future results and no representation or warranty, express or implied, is made regarding future performance. Except as required by any applicable law or regulation, James Fisher expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any forward looking statements contained in this announcement to reflect any change in the Group's expectations or any change in events, conditions or circumstances on which any such statement is based after the date of this announcement, or to keep current any other information contained in this announcement. Accordingly, undue reliance should not be placed on any forward-looking statements.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTSEUFMUESSEDL
Date   Source Headline
9th Jun 20269:04 amRNSDirector/PDMR Shareholding
22nd May 202612:22 pmRNS-RNotice of Defence Division Investor Event
18th May 20269:30 amRNSDirector/PDMR Shareholding
13th May 20261:48 pmRNSResult of AGM
22nd Apr 202611:15 amRNSDirector/PDMR Shareholding
8th Apr 20269:28 amRNSAnnual Report and Accounts and Notice of AGM
12th Mar 20267:00 amRNSPreliminary results for the year ended 31 Dec 2025
12th Mar 20267:00 amRNSPreliminary results for the year ended 31 Dec 2025
16th Feb 20267:00 amRNSNotice of Analyst and Investor Presentations
13th Feb 20263:10 pmRNSHolding(s) in Company
29th Jan 20267:00 amRNSFull Year Trading Update and Notice of Results
27th Jan 20262:05 pmRNSHolding(s) in Company
15th Jan 20262:00 pmRNSBlock Listing Six Monthly Return
2nd Oct 20257:00 amRNSHolding(s) in Company
26th Sep 20254:08 pmRNSHolding(s) in Company
26th Sep 20258:35 amRNSHolding(s) in Company
9th Sep 20257:00 amRNSHalf Year Results
21st Aug 20257:00 amRNSNotice of Analyst and Investor Presentations
1st Aug 20258:00 amRNSTotal Voting Rights and Share Capital
29th Jul 20257:00 amRNSHalf Year Trading Update and Notice of Results
16th Jul 20257:00 amRNSTotal Voting Rights and Share Capital
16th Jun 20254:35 pmRNSBlock listing six monthly return
23rd May 202511:46 amRNSBlock Listing Application
13th May 20252:36 pmRNSResults of Annual General Meeting
6th May 202510:39 amRNSNotification of Directors' Interest in Shares
28th Apr 20252:33 pmRNSNotification of Directors' Interest in Shares
4th Apr 20259:30 amRNSAnnual Report and Accounts 2024 and Notice of AGM
20th Mar 20257:00 amRNSFull Year Results
14th Mar 20259:00 amRNSNotice of Analyst and Investor Presentations
5th Feb 20257:00 amRNSFull Year Trading Update and Notice of Results
17th Jan 20257:56 amRNSHolding(s) in Company
16th Jan 20259:58 amRNSHolding(s) in Company
16th Dec 202410:59 amRNSBLOCK LISTING SIX MONTHLY RETURN
23rd Sep 20243:35 pmRNSDirector/PDMR Shareholding
19th Sep 20247:00 amRNSSigning of £95m of committed bank facilities
10th Sep 20247:00 amRNSHalf year results
6th Sep 20242:10 pmRNSCompletion of Disposal of Martek Holdings Limited
8th Jul 20244:19 pmRNSHolding(s) in Company
8th Jul 202410:04 amRNSCompletion of RMSpumptools Disposal
28th Jun 20249:26 amRNSDirector Declaration
17th Jun 202411:32 amRNSBlock listing six monthly return
13th Jun 20246:15 pmRNSResults of the General Meeting
12th Jun 20241:43 pmRNSNotification of Directors' Interests in Shares
30th May 20244:48 pmRNSResults of Annual General Meeting
30th May 20243:34 pmRNSDirector Declaration
24th May 20243:18 pmRNSPublication of Circular and Notice of GM
29th Apr 20245:39 pmRNSAnnual Report and Accounts 2023 and Notice of AGM
16th Apr 20247:00 amRNSPreliminary results for the year ended 31 Dec 2023
22nd Mar 20247:00 amRNSProposed disposal of RMSpumptools business
16th Feb 20244:30 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.